Gene Fusions in Pediatric Sarcomas (R21)
Funding Opportunity Number: PA-16-252 Opportunity Category: DiscretionaryFunding Instrument Type: GrantCategory of Funding Activity: EducationHealthCFDA Number: 93.396Eligible Applicants State governmentsCounty governmentsCity or township governmentsSpecial district governmentsIndependent school districtsPublic and State controlled institutions of higher educationNative American tribal governments (Federally recognized)Public housing authorities/Indian housing authoritiesNative American tribal organizations (other than Federally recognized tribal governments)Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher educationNonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher educationPrivate institutions of higher educationFor profit organizations other than small businessesSmall businessesOthers (see text field entitled "Additional Information on Eligibility" for clarification)Agency Name: HHS-NIH11Closing Date: May 07, 2019Award Ceiling: $200,000Expected Number of Awards: Creation Date: May 10, 2016Funding Opportunity Description: The overall goal of this funding opportunity announcement (FOA) is to encourage research grant applications to investigate the molecular mechanisms by which oncogenic fusion genes and their gene products contribute to pediatric sarcoma initiation, progression, and metastasis. Better understanding of the molecular pathways activated by ch...
Source: Grants.gov - Category: Research Tags: Education Health Source Type: funding
More News: Cancer | Cancer & Oncology | Education | Funding | Genetics | Grants | Health | Pediatrics | Research | Sarcomas | Universities & Medical Training